📰 Prospectus Rules News
Page 10 - Prospectus Rules News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prospectus Rules. Real-time updates on events, politics, business and more.
February 18, 2022
Investegate announcements from Rights and Issues Investment T, Final Results for the year to 31st December 2021
February 18, 2022
DJ Rights and Issues Investment Trust PLC: Final Results for the year to 31st December 2021 Rights and Issues Investment Trust PLC (RIII) Rights and Issues Investment Trust PLC: Final Results for
February 18, 2022
DJ Rights and Issues Investment Trust PLC: Final Results for the year to 31st December 2021 Rights and Issues Investment Trust PLC (RIII) Rights and Issues Investment Trust PLC: Final Results for
February 18, 2022
DJ Rights and Issues Investment Trust PLC: Final Results for the year to 31st December 2021 Rights and Issues Investment Trust PLC (RIII) Rights and Issues Investment Trust PLC: Final Results for
February 18, 2022
DJ Rights and Issues Investment Trust PLC: Final Results for the year to 31st December 2021 Rights and Issues Investment Trust PLC (RIII) Rights and Issues Investment Trust PLC: Final Results for
February 18, 2022
DJ Rights and Issues Investment Trust PLC: Final Results for the year to 31st December 2021 Rights and Issues Investment Trust PLC (RIII) Rights and Issues Investment Trust PLC: Final Results for
February 16, 2022
16.02.2022 - Regulatory News: Aelis Farma (Paris: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases (the Company), announces today the successful completion of its initial public offering on ...
February 15, 2022
Capital increase of approximately €25 million, i.e. 100% of the initial objective, despite high market volatility Size of the transaction which may be increased to approximately €25.55 million
February 2, 2022
02.02.2022 - Regulatory News: Not to be distributed, directly or indirectly, in the United States of America, Canada, Australia, Japan or South Africa. Aelis Farma, a clinical-stage biopharmaceutical company specializing in the development of treatments for ...
February 2, 2022
Capital increase of €25 million, which may be increased to a maximum of approximately €33 million in the event the Extension Clause and the Over-Allotment Option are fully exercised Irrevocable